Clinical Trials
1
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer
- First Posted Date
- 2013-12-30
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- Novartis Healthcare A/S
- Target Recruit Count
- 7
- Registration Number
- NCT02023359
- Locations
- 🇩🇰
Aalborg Universitetshospital, Clinical Research unit Department of oncology, Klinik Kirurgi-kræft, Hobrovej 18-22, Aalborg, Denmark
🇩🇰Onkologisk Afdelning, SVS Esbjerg, Esbjerg, Denmark
🇩🇰Department of Oncology, Odense University Hospital, Odense, Denmark
News
No news found